Real-time enrollment status for this amyotrophic lateral sclerosis (als) clinical trial
Current Status
Recruiting
Checked: September 12, 2026 at 3:36 PM UTC
| NCT Number | NCT07023835 |
| Recruiting Status | Recruiting |
| Condition | Amyotrophic Lateral Sclerosis (ALS) |
| Phase | PHASE2 |
| Target Enrollment | 240 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Zydus Therapeutics Inc. |
| Last Updated on CT.gov | September 1, 2026 (1 week ago) |
As of September 12, 2026: Clinical trial NCT07023835 is currently recruiting participants. This phase2 study for amyotrophic lateral sclerosis (als) is actively seeking new participants at 15 locations across the United States. The study is sponsored by Zydus Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07023835 is actively recruiting participants as of September 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07023835 was last updated 1 week ago (September 1, 2026). HelloStudys verifies this status automatically.